LeMaitre Vascular (LMAT) News Today → Time is Running Out - June 25th Deadline Approaching! (From Paradigm Press) (Ad) Free LMAT Stock Alerts $77.48 -0.31 (-0.40%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 6 at 1:24 AM | americanbankingnews.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Recommendation of "Moderate Buy" by BrokeragesJune 5 at 7:53 PM | marketbeat.comAnnex Advisory Services LLC Purchases 12,745 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)Annex Advisory Services LLC lifted its position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 105.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 24,834 shares of the medical instruments supplier's stock after acquiring an additionalJune 4, 2024 | americanbankingnews.comAnalysts Issue Forecasts for LeMaitre Vascular, Inc.'s Q1 2025 Earnings (NASDAQ:LMAT)June 3, 2024 | marketbeat.comLeMaitre Vascular, Inc. to Post Q1 2025 Earnings of $0.50 Per Share, Roth Capital Forecasts (NASDAQ:LMAT)LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) - Research analysts at Roth Capital issued their Q1 2025 earnings estimates for shares of LeMaitre Vascular in a research report issued on Friday, May 31st. Roth Capital analyst J. Wittes anticipates that the medical instruments supplier will poJune 1, 2024 | americanbankingnews.comLeMaitre Vascular (NASDAQ:LMAT) Upgraded to "Strong-Buy" at Roth CapitalJune 1, 2024 | americanbankingnews.comLeMaitre Vascular (NASDAQ:LMAT) Receives "Buy" Rating from Roth MkmMay 31, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Given "Buy" Rating at Roth MkmRoth Mkm restated a "buy" rating and set a $100.00 price target on shares of LeMaitre Vascular in a report on Friday.May 30, 2024 | marketbeat.comTrexquant Investment LP Has $1.12 Million Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Trexquant Investment LP cut its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 34.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 19,738 shares of the medical instruments supplier's stock after selling 10,595May 22, 2024 | money.usnews.comLemaitre Vascular IncMay 21, 2024 | globenewswire.comLeMaitre to Present at the Jefferies Global Healthcare ConferenceMay 21, 2024 | insidertrades.comInsider Selling: LeMaitre Vascular, Inc. (NASDAQ:LMAT) Director Sells 5,500 Shares of StockMay 20, 2024 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Director Bridget A. Ross Sells 5,500 SharesLeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) Director Bridget A. Ross sold 5,500 shares of LeMaitre Vascular stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $77.99, for a total transaction of $428,945.00. Following the sale, the director now directly owns 2,278 shares of the company's stock, valued at approximately $177,661.22. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.May 20, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Reaches New 12-Month High at $79.41LeMaitre Vascular (NASDAQ:LMAT) Reaches New 12-Month High at $79.41May 13, 2024 | marketbeat.comSummit Creek Advisors LLC Raises Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Summit Creek Advisors LLC increased its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 37.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 228,501 shares of the medical instruments supplier's stocMay 13, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Hits New 12-Month High at $76.26LeMaitre Vascular (NASDAQ:LMAT) Reaches New 52-Week High at $76.26May 13, 2024 | marketbeat.comLeMaitre Vascular, Inc. to Issue Quarterly Dividend of $0.16 (NASDAQ:LMAT)LeMaitre Vascular, Inc. (NASDAQ:LMAT) declared a quarterly dividend on Tuesday, April 30th. Stockholders of record on Thursday, May 16th will be given a dividend of 0.16 per share by the medical instruments supplier on Thursday, May 30th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.84%. The ex-dividend date is Wednesday, May 15th.May 11, 2024 | marketbeat.comMesirow Institutional Investment Management Inc. Acquires Shares of 155,682 LeMaitre Vascular, Inc. (NASDAQ:LMAT)Mesirow Institutional Investment Management Inc. bought a new position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 155,682 shares of the medicalMay 11, 2024 | finance.yahoo.comWhy You Might Be Interested In LeMaitre Vascular, Inc. (NASDAQ:LMAT) For Its Upcoming DividendMay 9, 2024 | insidertrades.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Director David B. Roberts Sells 5,025 SharesMay 8, 2024 | marketbeat.comInsider Selling: LeMaitre Vascular, Inc. (NASDAQ:LMAT) Director Sells 5,025 Shares of StockLeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) Director David B. Roberts sold 5,025 shares of LeMaitre Vascular stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $75.62, for a total value of $379,990.50. Following the completion of the sale, the director now directly owns 14,114 shares in the company, valued at approximately $1,067,300.68. The sale was disclosed in a legal filing with the SEC, which is available at this link.May 6, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Reaches New 12-Month High After Analyst UpgradeLeMaitre Vascular (NASDAQ:LMAT) Hits New 1-Year High on Analyst UpgradeMay 5, 2024 | finance.yahoo.comLeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their PredictionsMay 4, 2024 | finance.yahoo.comLeMaitre Vascular First Quarter 2024 Earnings: Beats ExpectationsMay 4, 2024 | marketbeat.comRussell Investments Group Ltd. Has $16.36 Million Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Russell Investments Group Ltd. raised its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 6.7% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 288,212 shares of the medical instruments supplier's stock after acquiring anMay 4, 2024 | finanznachrichten.deLeMaitre Vascular, Inc.: LeMaitre Q1 2024 Financial ResultsMay 3, 2024 | marketbeat.comStockNews.com Upgrades LeMaitre Vascular (NASDAQ:LMAT) to BuyStockNews.com raised LeMaitre Vascular from a "hold" rating to a "buy" rating in a research note on Friday.May 3, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Posts Quarterly Earnings Results, Beats Estimates By $0.05 EPSLeMaitre Vascular (NASDAQ:LMAT - Get Free Report) issued its earnings results on Thursday. The medical instruments supplier reported $0.44 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.05. LeMaitre Vascular had a return on equity of 10.57% and a net margin of 15.56%. The business had revenue of $53.48 million for the quarter, compared to analysts' expectations of $51.50 million. During the same period in the previous year, the firm posted $0.27 EPS. The business's revenue for the quarter was up 13.6% compared to the same quarter last year.May 3, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Price Target Raised to $77.00JMP Securities increased their price objective on shares of LeMaitre Vascular from $72.00 to $77.00 and gave the company a "market outperform" rating in a report on Friday.May 3, 2024 | markets.businessinsider.comKeyBanc Keeps Their Hold Rating on Lemaitre Vascular (LMAT)May 3, 2024 | markets.businessinsider.comOppenheimer Reaffirms Their Buy Rating on Lemaitre Vascular (LMAT)May 3, 2024 | finance.yahoo.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Q1 2024 Earnings Call TranscriptMay 3, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Arbutus Biopharma (ABUS), Lemaitre Vascular (LMAT)May 3, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Releases Q2 2024 Earnings GuidanceLeMaitre Vascular (NASDAQ:LMAT) updated its second quarter 2024 earnings guidance. The company provided EPS guidance of 0.450-0.500 for the period, compared to the consensus estimate of 0.440. The company also issued revenue guidance of $53.7 millionillion-$56.1 millionillion, compared to the consensus estimate of $54.3 millionillion.May 2, 2024 | investorplace.comLMAT Stock Earnings: LeMaitre Vascular Beats EPS, Beats Revenue for Q1 2024May 2, 2024 | finance.yahoo.comLeMaitre Vascular Inc (LMAT) Q1 2024 Earnings: Surpasses Analyst Revenue ForecastsMay 2, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Releases FY24 Earnings GuidanceLeMaitre Vascular (NASDAQ:LMAT) updated its FY24 earnings guidance. The company provided EPS guidance of $1.73-1.84 for the period, compared to the consensus estimate of $1.65. The company also issued revenue guidance of $212.7-217.3 millionillion, compared to the consensus estimate of $211.69 millionillion.May 2, 2024 | globenewswire.comLeMaitre Q1 2024 Financial ResultsApril 27, 2024 | msn.comStifel Upgrades LeMaitre Vascular (LMAT)April 26, 2024 | markets.businessinsider.comBuy Rating Affirmed: LeMaitre Vascular’s Growth and Profitability OutlookApril 26, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Upgraded to "Buy" by Stifel NicolausStifel Nicolaus upgraded LeMaitre Vascular from a "hold" rating to a "buy" rating and increased their target price for the company from $59.00 to $75.00 in a report on Friday.April 19, 2024 | globenewswire.comLeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024April 19, 2024 | finance.yahoo.comLeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?April 18, 2024 | finance.yahoo.comLeMaitre Vascular, Inc. (LMAT)April 6, 2024 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Purchased by Vanguard Group Inc.Vanguard Group Inc. raised its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 2.3% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,510,567 shares of the medical instruApril 5, 2024 | finance.yahoo.comWhen Should You Buy LeMaitre Vascular, Inc. (NASDAQ:LMAT)?March 31, 2024 | marketbeat.comCopeland Capital Management LLC Has $71.52 Million Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Copeland Capital Management LLC lifted its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 2.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,259,961 shares of the medical inMarch 27, 2024 | benzinga.comEngaging In Options Activity, George LeMaitre Exercises Options Valued At $266K In LeMaitre VascularMarch 26, 2024 | globenewswire.comLeMaitre to Present at the 23rd Annual Needham Virtual Healthcare ConferenceMarch 22, 2024 | finance.yahoo.comInvesting in LeMaitre Vascular (NASDAQ:LMAT) five years ago would have delivered you a 137% gainMarch 17, 2024 | insidertrades.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Director Sells $344,925.00 in Stock Get LeMaitre Vascular News Delivered to You Automatically Sign up to receive the latest news and ratings for LMAT and its competitors with MarketBeat's FREE daily newsletter. Email Address A Wave of Creative Destruction Set to Strike June 30 (Ad)You have until June 30 … then all hell will begin to break loose… The White House and Goldman Sachs predict generative AI will soon replace up to 300 MILLION jobs — one in every four careers … worldwide. Click here for details. LMAT Media Mentions By Week LMAT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LMAT News Sentiment▼0.910.72▲Average Medical News Sentiment LMAT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LMAT Articles This Week▼73▲LMAT Articles Average Week Get LeMaitre Vascular News Delivered to You Automatically Sign up to receive the latest news and ratings for LMAT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: GKOS News MMSI News HAE News INSP News PRCT News AXNX News TNDM News NARI News IRTC News ICUI News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LMAT) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredWarren Buffett & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredThe new masters of energyAccording to one source, this new grid could soon provide energy to “one billion people in the world who don’t...Porter & Company | SponsoredWe’ve Made 1,000% … THREE Different Times in the Last Year (Here’s How)Bitcoin can and probably will hit the $1 MILLION level this decade. That’s more than 1,000% upside from the...Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | Sponsored